Back to discover
Disease

Hepatic veno-occlusive disease

Late-stage therapeutic development
Also known as Budd Chiari Syndrome, hepatic Vod, liver veno-occlusive disease, sinusoidal obstruction syndrome+1 more

Budd Chiari Syndrome, hepatic Vod, liver veno-occlusive disease, sinusoidal obstruction syndrome, veno-occlusive disease.

3
Clinical trials
1
Associated genes
1
Related proteins
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Approval: Defitelio (EMA)

Regulatory2013-10-18EMA

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Therapeutic landscape

Therapies with a regulatory footing for this condition, alongside the wider set of agents co-studied with it in the literature.

Approved & established therapies
Defibrotideapproved

Approval — Defitelio is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) a… (2013)

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Regulatory timeline

Drug regulatory events matched to this condition by indication — EMA.

First approvals
2013emaApprovalDefibrotide· Defitelio is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstructive syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age. source ↗

European Medicines Agency (CC BY 4.0). Events are matched to this condition by drug indication text — approvals/updates for drugs indicated for it, not disease-specific acts.

Associated genes

1 match

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Disease biology

1 match

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.

Synonyms

Budd Chiari Syndrome, hepatic Vod, liver veno-occlusive disease, sinusoidal obstruction syndrome, veno-occlusive disease

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.